Interviews

Addressing muscle loss associated with GLP-1 medication use

April 2, 2024 - Glucagon-like peptide-1 (GLP-1) receptor agonists — also known as GLP-1 drugs — have gained a significant amount of attention in recent years because of their utility in managing type 2 diabetes (T2D) and, even more so, in weight management for overweight or obese adults. Despite the scientifically proven benefits of these drugs, there are many challenges posed by their...

Read More


More Articles

Comparing inflammatory bowel disease treatment options

by Veronica Salib

Last month, AbbVie sponsored several presentations and posters at the European Crohn's and Colitis Organization’s (ECCO) annual congress. Among these abstracts was the SEQUENCE study, which compared risankizumab and ustekinumab...

Manufacturing complex pharmaceutical products with new technologies

by Veronica Salib

Scientific advancement and increasingly complex pharmaceutical products have reshaped the healthcare industry, providing novel tools and solutions for managing broad conditions, from acute viral infections to chronic diseases to oncology....

Developing Quality Assurance Standards for Biologics, Biosimilars

by Veronica Salib

Biologics and biosimilars are a rapidly growing sector of the biopharmaceutical industry. However, as the field grows, multiple challenges arise in the manufacturing and quality assurance guidelines for biologics and...

What Is the Role of the Accelerating Medicines Partnership?

by Veronica Salib

Last week, the Foundation for the National Institutes of Health (FNIH) held its inaugural Accelerating Medicines Partnership (AMP) Program Symposium, discussing the progress of multiple AMP projects. Julie Gerberding, MD, MPH, President...

Digitizing the Biopharmaceutical Supply Chain Improves Resilience

by Veronica Salib

Throughout the past few years, global, national, and industry-specific changes have posed challenges to the biopharmaceutical supply chain. Disruptions and shortages have caused industry leaders and regulatory organizations to look for...

Exploring Gene and Cell Therapy Integration in Pharmacies

by Alivia Kaylor

After seeing promising results in cell and gene therapy clinical trials, cell and gene therapy is transforming patient care, offering new possibilities for treating diseases that previously had limited treatment options. As pharmacies...

Exploring and Managing GLP-1 Receptor Agonists in Weight Loss

by Veronica Salib

Over the past few years, weight loss drugs like Ozempic and Wegovy have received extensive attention in mainstream media for their weight loss effects. Beyond attention from the general public, this class of medications, the glucagon-like...

How the Medical Education System Contributes to Physician Burnout

by Veronica Salib

One could argue that the medical education system is the cornerstone of healthcare and patient care. Through the education and certification protocols, medical schools mold the providers that play a critical role in nearly every aspect of...

Exploring Data Analytics in Pharmaceutical Marketing

by Veronica Salib

As the global understanding of data analytics advances and new techniques come to fruition, nearly every industry is assessing how they can leverage analytics to improve outcomes for their stakeholders. The pharmaceutical industry is...

Optimizing Cancer Care Pathways Through Precision Medicine, RWD

by Editorial Staff

Personalized medicine is vital because it streamlines clinical decision-making through genetic tests or biomarkers. Essentially, personalized care lets caregivers feel more confident that a patient will respond to a specific drug or be...

Ensuring Equal Clinical Trial Access Across Vulnerable Communities

by Editorial Staff

Clinical trials play a critical role in ensuring the widespread safety of medical products for patients by analyzing product efficacy, safety, and indications. Since clinical trial data is used to guide drug approvals and standards of care...

Exploring Pharmacy Benefit Manager Reforms: Transparency

by Veronica Salib

Pharmacy benefit managers (PBMs) have received criticism over the past couple of years for pocketing savings intended for patients. While this rhetoric is true for some PBMs, a small subset of the market advocates for PBM transparency and...

How to Effectively Integrate AI into Clinical Trials

by Veronica Salib

Since its inception, artificial intelligence (AI) has continually disrupted practices across all industries. As more and more healthcare researchers and clinicians adopt AI, experts have noted the impact of AI on clinical research and...

Evaluating the Breast Cancer Therapeutics Market

by Veronica Salib

As breast cancer awareness month continues, gathering a comprehensive understanding of the breast cancer therapeutics market is critical, including current trends and market players, gaps, and predictions for the coming year. Understanding...

The Importance of Accurately Measuring the Value of New Medications

by Veronica Salib

Last month, No Patient Left Behind, an American nonprofit organization pushing for healthcare reform in the United States to make drugs more affordable, published a report assessing the accuracy and utility of current cost-effectiveness...

How Can Pharmaceutical Companies Meet Drug Launch Expectations

by Veronica Salib

Earlier this month, Deloitte published a report evaluating why so many drug launches failed to meet their expectations. According to data analyzed by the Deloitte Center for Health Solutions through the Life Sciences and Healthcare...

Vaccinations Needed to Prevent COVID-19 ED Visits, Hospitalization

by Veronica Salib

The coronavirus pandemic has had detrimental impacts on communities across the United States, causing emergency department visits (ED visits), hospitalizations, long-term chronic diseases, financial losses, deaths, and more. The...

GSK Launches New Platform for Tracking Adult Vaccination Rates

by Veronica Salib

As healthcare professionals and public health leaders continue expressing concerns about adult vaccination rates post-pandemic, GSK has launched its new COiMMUNITY Initiative to improve adult vaccine uptake. As part of the initiative, GSK...

How Inflation, Competition, Biosimilars Affect Prescription Drug Costs

by Editorial Staff

As the inflation rate continues to rise, the healthcare industry — like every other industry — is taxed with extraordinarily high costs. Rising drug prices have caused increased healthcare expenditures and out-of-pocket costs....

Recent Articles